Patents by Inventor Edgar Joel Acosta Zara

Edgar Joel Acosta Zara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230146954
    Abstract: The present disclosure relates to micellar compositions conformed by biomimetic phospholipids and nonionic surfactants, among other ingredients, for eliminating one or more types of microorganisms including mycobacteria, bacteria, fungi, and viruses from a surface within a contact time on the surface of less than about 1 minutes and having pH of from about 0.3 to 8. The present invention aims on using 100% bio-based (renewable) biodegradable, non-toxic ingredients to be applied not only to hard inanimate surfaces but also on tissue for endodontic applications.
    Type: Application
    Filed: February 26, 2021
    Publication date: May 11, 2023
    Inventors: Americo C. Boza Troncoso, Edgar Joel Acosta Zara, Dorin Cioraca
  • Patent number: 9918934
    Abstract: The present invention relates to biocompatible microemulsion systems designed for controlled release drug delivery applications formulated with phospholipids such as lecithin (surfactant), a lipophilic additive (linker) containing 9 or more carbons in their alkyl group and hydrophilic-lipophilic balance (HLB) of 5 or less, and a surfactant-like hydrophilic additive (linker) containing between 6 to 9 carbon atoms in their alkyl tail. The combination of linkers and phospholipids produce formulations capable of delivering high concentrations of poorly soluble drugs into epithelial tissue using low surfactant concentrations, with minimum cytotoxic side effects.
    Type: Grant
    Filed: December 12, 2006
    Date of Patent: March 20, 2018
    Inventors: Edgar Joel Acosta-Zara, Shuhong Yuan
  • Publication number: 20090093389
    Abstract: A novel method for cleaning dental and medical instruments is disclosed, in which a cleaning solution including a low-residue corrosion inhibitor is used not only in a wash stage of the cleaning cycle, but also in at least one subsequent rinse cycle, to optimize both cleaning and rust prevention. A novel cleaning solution particularly suited to this method has a neutral to alkaline pH and comprises in aqueous solution a low-foaming surfactant and a corrosion inhibitor selected from the group of C4-C16 alkyl pyrrolidones and C1-C18 alkylamines.
    Type: Application
    Filed: December 8, 2008
    Publication date: April 9, 2009
    Inventors: Veso Tijanic, Bhupinder Bharaj, Edgar Joel Acosta Zara, Navid Omidbakhsh
  • Patent number: 7462586
    Abstract: A novel method for cleaning dental and medical instruments is disclosed, in which a cleaning solution including a low-residue corrosion inhibitor is used not only in a wash stage of the cleaning cycle, but also in at least one subsequent rinse cycle, to optimize both cleaning and rust prevention. A novel cleaning solution particularly suited to this method has a neutral to alkaline pH and comprises in aqueous solution a low-foaming surfactant and a corrosion inhibitor selected from the group of C4-C16 alkyl pyrrolidones and C1-C18 alkylamines.
    Type: Grant
    Filed: February 14, 2006
    Date of Patent: December 9, 2008
    Assignee: Scican Ltd.
    Inventors: Veso Tijanic, Bhupinder Bharaj, Edgar Joel Acosta Zara, Navid Omidbakhsh
  • Publication number: 20080139392
    Abstract: The present invention relates to biocompatible microemulsion systems designed for controlled release drug delivery applications formulated with phospholipids such as lecithin (surfactant), a lipophilic additive (linker) containing 9 or more carbons in their alkyl group and hydrophilic-lipophilic balance (HLB) of 5 or less, and a surfactant-like hydrophilic additive (linker) containing between 6 to 9 carbon atoms in their alkyl tail. The combination of linkers and phospholipids produce formulations capable of delivering high concentrations of poorly soluble drugs into epithelial tissue using low surfactant concentrations, with minimum cytotoxic side effects.
    Type: Application
    Filed: December 12, 2006
    Publication date: June 12, 2008
    Inventors: Edgar Joel Acosta-Zara, Shuhong Yuan